| | EAC group
(n = 208) | PAC group
(n = 245) | P value |
| | Eradication rate | | | | | Intention-to-treat | 72% (150/208) | 55% (135/245) | <.05 | | Per-protocol | 91% (150/165) | 72% (135/187) | <.05 | | Adverse events | 19% (39/208) | 17% (42/245) | .712 | | Compliance | 87% (181/208) | 91% (223/245) | .083 |
|
|